CAPS1 Negatively Regulates Hepatocellular Carcinoma Development through Alteration of Exocytosis-Associated Tumor

Ruyi Xue1, Wenqing Tang2, Pingping Dong3

  • 1Department of Gastroenterology and Hepatology, Shanghai Institute of Liver Diseases, Zhongshan Hospital of Fudan University, Shanghai 200032, China. xue.ruyi@zs-hospital.sh.cn.

Insights

Calcium-dependent activator protein for secretion 1 (CAPS1) acts as a tumor suppressor in hepatocellular carcinoma (HCC). Loss of CAPS1 correlates with aggressive HCC, while its overexpression inhibits tumor growth and proliferation.

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Neuroscience

Background:

  • Calcium-dependent activator protein for secretion 1 (CAPS1) is crucial for dense-core vesicle (DCV) exocytosis in neurons and neuroendocrine cells.
  • The function of CAPS1 in cancer, particularly hepatocellular carcinoma (HCC), is not well understood.

Purpose of the Study:

  • To investigate the role of CAPS1 in the development and progression of hepatocellular carcinoma (HCC).
  • To evaluate CAPS1 expression levels and its prognostic significance in HCC patients.

Main Methods:

  • Quantified CAPS1 expression in eight hepatoma cell lines and 141 HCC patient specimens.
  • Assessed the correlation between CAPS1 expression and clinical parameters, including tumor grade and metastasis.
  • Investigated the functional impact of CAPS1 overexpression on hepatoma cell proliferation, migration, and tumor growth in vitro and in vivo models.

Main Results:

  • Reduced CAPS1 expression in HCC tissues significantly correlated with advanced tumor-node-metastasis (TNM) stage and lack of tumor encapsulation.
  • Lower CAPS1 levels were associated with poorer overall survival and increased recurrence rates in HCC patients.
  • Overexpression of CAPS1 suppressed hepatoma cell proliferation and migration in vitro and inhibited xenograft tumor growth in vivo, suggesting modulation of the tumor microenvironment.

Conclusions:

  • CAPS1 functions as a tumor suppressor in hepatocellular carcinoma.
  • CAPS1 expression is a potential prognostic biomarker for HCC.
  • Targeting CAPS1 or its pathways may offer therapeutic strategies for HCC.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.9K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.5K